Cargando…

Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study

OBJECTIVE: Colloid solutions are commonly used to maintain perioperative fluid homeostasis. In regard to perioperative infant-centered care, data about the impact of colloids are rare. New data suggest a possible positive effect of hydroxyethyl starch (HES) concerning blood brain barrier. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schick, Martin A., Pippir, Jonas, Struck, Manuel F., Brugger, Jürgen, Neuhaus, Winfried, Wunder, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627096/ https://www.ncbi.nlm.nih.gov/pubmed/34838152 http://dx.doi.org/10.1186/s13104-021-05836-w

Ejemplares similares

Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation
por: Schick, Martin Alexander, et al.
Publicado: (2015)

Hydroxyethylstarch revisited for acute brain injury treatment
por: Schick, Martin A., et al.
Publicado: (2020)

Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury
por: Boussekey, Nicolas, et al.
Publicado: (2010)

Does volume substitution with HES 130/0.4 affect renal safety in abdominal aortic surgery?
por: Godet, G, et al.
Publicado: (2006)

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
por: Gandhi, S, et al.
Publicado: (2005)

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
por: Ertmer, C, et al.
Publicado: (2011)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Inflammatory Kidney and Liver Tissue Response to Different Hydroxyethylstarch (HES) Preparations in a Rat Model of Early Sepsis
por: Schimmer, Ralph C., et al.
Publicado: (2016)

HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function
por: Sossdorf, Maik, et al.
Publicado: (2009)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study
por: Guidet, Bertrand, et al.
Publicado: (2012)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Effects of colloid-based (hydroxyethylstarch 6% 130/0.42, gelafundin 4%) and crystalloid-based volume regimes in cardiac surgery: a retrospective analysis
por: Datzmann, Thomas, et al.
Publicado: (2022)

Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective
por: Martini, Judith, et al.
Publicado: (2008)

Concerns about renal safety of HES 130
por: Wiedermann, Christian J, et al.
Publicado: (2013)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
por: Zampieri, Fernando Godinho, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Hydroxyethylstarch 200/0.5 - the horse has bolted
por: Soni, Neil
Publicado: (2012)

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery
por: Winterhalter, M, et al.
Publicado: (2010)

HES 130 kD, but not crystalloid volume support reduces leukocyte–endothelial cell interaction during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution’s Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography
por: Akay, Meltem Olga, et al.
Publicado: (2014)

Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
por: Hahn, Robert G, et al.
Publicado: (2013)

Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma
por: Lukasewitz, Peter, et al.
Publicado: (2023)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients
por: Schortgen, Frédérique, et al.
Publicado: (2003)

Neutrophil elastase suppression by medium-molecular-weight hydroxyethylstarch in orthopaedic surgery
por: Walker, R, et al.
Publicado: (2007)

Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
por: Wong, Yuk Lung, et al.
Publicado: (2015)

Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012)

Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study
por: Miyao, Hideki, et al.
Publicado: (2020)

Correction: Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
Publicado: (2015)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
por: Costa, MG, et al.
Publicado: (2003)

The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials
por: Wei, Ling, et al.
Publicado: (2021)

10% Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage
por: Siegemund, Martin
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fcj5a7m6ddr7ogfh80u02dab9h